Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

ADC Therapeutics readies IPO [Seeking Alpha]

Seagen Inc. (SGEN) 
Last seagen inc. earnings: 4/30 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.seattlegenetics.com
Company Research Source: Seeking Alpha
ADC Therapeutics readies IPO ADC Therapeutics SA ADCT prospectus The Swiss biotech develops antibody-drug conjugates (ADCs) to treat cancer that use pyrrobenzodiazepines actinomycetes Lead candidates are ADCT-402 ADCT-301 If current studies are successful, the company expects to file a U.S. marketing application for ADCT-402 in H2 2020 followed by ADCT-301 in H1 2022. 2019 Financials Related ticker: Seattle Genetics (NASDAQ: SGEN Show less Read more
Impact Snapshot
Event Time:
SGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SGEN alerts
Opt-in for
SGEN alerts

from News Quantified
Opt-in for
SGEN alerts

from News Quantified